HCL Technologies experienced a decline in today's trading session, with its shares falling by 1.06% to a price of Rs 1,562.50. The trading volume was notably high, indicating significant market ...

On stocks to buy on Wednesday, Sagar Doshi of Nuvama recommended three stocks - Divis Laboratories Ltd, HCL Technologies Ltd, and Marico Ltd. A 6 month consolidation is breaking out on charts of ...

The U.S. Capitol is seen on Capitol Hill in Washington, D.C., U.S., May 7, 2025. REUTERS/Nathan Howard/File Photo The cost of insuring exposure to U.S. government debt has climbed noticeably over ...

BMS is a longstanding player in cardiovascular with drugs like Pfizer-partnered Eliquis (apixaban) and Sanofi-partnered Plavix (clopidogrel), but over the last few years has been directing its R&D ...

Anticoagulants and antiplatelet agents pose a great risk in patients undergoing surgery. Because these products inhibit at least one, and often multiple, factors in the clotting cascade, patients ...

Like Plavix ®, there are many other examples and as a result, of every 10 people who go to a pharmacy to get their prescription, seven leave empty handed because they cannot afford their ...

HCL Tech's shares closed at Rs 1568.60 yesterday, up 0.67%, with a trading volume of 1,012,225 shares.

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

HCL Technologies Ltd. key Products/Revenue Segments include Software Development Charges and Computer Hardware & Software for the year ending 31-Mar-2024.For the quarter ended 31-03-2025, the company ...

Visit a quote page and your recently viewed tickers will be displayed here.